Description
Indications
Suitable for glycemic control in adults with type 2 diabetes, either as monotherapy or in combination with other glucose-lowering medicines.
Mécanisme d’action
Rybelsus is a GLP-1 receptor agonist that mimics human GLP-1, selectively binds to the GLP-1 receptor, increases cAMP signaling, promotes insulin secretion, suppresses glucagon release, and helps lower blood glucose levels.
Posologie
Recommended dosage:
Precautions
Special populations: pregnant women, breastfeeding women, children, and older adults should use it only under medical supervision.
